SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Celltech Group (NYSE: CLL)
An SI Board Since January 2000
Posts SubjectMarks Bans
123 10 0
Emcee:  Tom Nealon Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
98Celltech Announces Completion of OGS "Integration" Process SLOUGH, UKnigel bates-11/19/2003
97<i>Some colour on the story</i> LONDON (Dow Jones)--Celltech Group nigel bates-11/13/2003
96>>Dr Goran Ando, Chief Executive Officer of Celltech commented: "We wIcebrg-11/13/2003
95Ouch indeed. <i>wonder if success of BMY drug influenced this</i> nigel bates-11/13/2003
94CDP 870 contd. ...Pfizer delay to CDP 870 RA trials In light of its continuing nigel bates-11/13/2003
93Ouch! Pfizer delay has come out of nowhere. wonder if success of BMY drug influeMadharry-11/13/2003
92Celltech Group plc -- Update on CDP 870 Clinical Development Programme SLOUGH,nigel bates-11/13/2003
91Marconi Corporation Sells JV Stake To Celltech Unit Wednesday November 12, 3:06 nigel bates-11/12/2003
90<i>Scancell SC101 - parking.</i> Nottingham, UK - 5th August 2003 -nigel bates-11/7/2003
89The company PR: SLOUGH, U.K., Oct. 30, 2003 (PRIMEZONE) -- Celltech Pharmaceutinigel bates-10/30/2003
88Celltech Group Licenses European Sales Rights To Xyrem Thursday October 30, 2:51nigel bates-10/30/2003
87<i>Zavesca figures (or rather, it doesn't yet...) from yesterday'snigel bates-10/29/2003
86Celltech Achieves Milestone in Osteoporosis Collaboration with Amgen SLOUGH, U.nigel bates-10/28/2003
85Seems that it's possible to get a PDE4 inhibitor to work, after all: BAD HOnigel bates-9/29/2003
84Celltech Group PLC Announces Merck Extends Development Period For PDE4 Collaboranigel bates-9/24/2003
83Access Pharmaceuticals, Inc. Announces Oral Drug Delivery Research Collaborationnigel bates-9/11/2003
82As expected, they canned CDP 571. Results were decent, but there's now onlnigel bates-9/1/2003
81From current CLL job ads.: <i> ...An extensive and potentially high-valuenigel bates-8/7/2003
80SLOUGH, U.K., August 1, 2003 (PRIMEZONE) -- Celltech Group plc (London:CCH.L - Nnigel bates-8/3/2003
79Seattle Genetics Achieves Milestones Under Antibody-Drug Conjugate Collaborationnigel bates-6/17/2003
78Celltech Group plc Zavesca Approved In Israel - Second largest patient populationigel bates-6/16/2003
77Research update: <pre> nigel bates-6/16/2003
76Big, left coast manager with plently of resources. Outstanding reputation, quiekeokalani'nui-6/6/2003
75Not really. If they carry on buying, I might do some DD. <pre>Celltech Grnigel bates-6/6/2003
74know anything about Capital group?Madharry-5/31/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News